Globus Medical (GMED) EBT Margin (2011 - 2026)
Globus Medical's (GMED) quarterly EBT Margin came in at 24.04% in Q2 2026, down 121.0% on a YoY basis from 114.47% in Q2 2025, and up 16.29% quarter-over-quarter from 20.67% in Q1 2026.
Powered by 
Analysis
Globus Medical (GMED) EBT Margin (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported EBT Margin for 16 consecutive years, with 24.04% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 121.0% year-over-year to 24.04%; the trailing twelve-month figure through Jun 2026 stood at 20.99% (up 677.0% YoY), and the FY2025 full-year result was 20.59%, up 1580.0% from the prior year.
- EBT Margin advanced to 24.04% in Q2 2026 per GMED's latest filing, from 20.67% in the prior quarter.
- Across five years, EBT Margin topped out at 26.76% in Q2 2022 and bottomed at 1.42% in Q1 2024.
- Historically, EBT Margin has averaged 16.39% across 5 years, with a median of 20.57% in 2026.
- The sharpest annual moves came in 2024 and 2025: EBT Margin slumped 2426 bps in 2024, then soared 1875 bps in 2025.
- Over 5 years, EBT Margin stood at 24.17% in 2022, then plunged by 83 bps to 4.05% in 2023, then decreased by 7 bps to 3.75% in 2024, then soared by 446 bps to 20.48% in 2025, then climbed by 17 bps to 24.04% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 24.04%, 20.67%, and 20.48% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn | 24.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.04% |
| Mar 31, 2026 | 20.67% |
| Dec 31, 2025 | 20.48% |
| Sep 30, 2025 | 18.72% |
| Jun 30, 2025 | 25.25% |
| Mar 31, 2025 | 17.33% |
| Dec 31, 2024 | 3.75% |
| Sep 30, 2024 | 9.11% |
| Jun 30, 2024 | 7.56% |
| Mar 31, 2024 | -1.42% |
| Dec 31, 2023 | 4.05% |
| Sep 30, 2023 | 0.66% |
| Jun 30, 2023 | 25.61% |
| Mar 31, 2023 | 22.84% |
| Dec 31, 2022 | 24.17% |
| Sep 30, 2022 | 24.18% |
| Jun 30, 2022 | 26.76% |
| Mar 31, 2022 | 21.21% |
| Dec 31, 2021 | 9.70% |
| Sep 30, 2021 | 23.70% |